SlideShare une entreprise Scribd logo
1  sur  13
Télécharger pour lire hors ligne
Naturally-occurring Phytoestrogen
 Precursors Are Converted to Estrogenic
Compounds by Human Intestinal Bacteria




                          Masao Hattori
              Emeritus Professor, University of Toyama




        On Plant Isoflavones and Lignans

In an epidemiologic study, the prevalence of breast cancer
and prostate cancer was lower in Japan and Finland
compared it with U.S.A
As a low factor of the prevalence, a Japanese soy bean and
Finnish rye bread were considered as the candidates, which
contain so called phytoestrogens, isoflavonoids and lignans.
Since phytoestrogens structurally resemble estradiol, they
have estrogenic and anti-estrogenic activities and an
incidence of prostate cancer or breast cancer may decrease
depending on the blood concentrations of phytoestrogens
(reverse correlation).
METABOLISM OF SDG BY HUMAN INTESTINAL FLORA




  METABOLISM OF ARCTIIN BY HUMAN
  INTESTINAL FLORA
CIRCULAR DICHROISM OF (+)- AND (-)-ENTEROLACTONES




 MIRROR IMAGES OF (+)- AND (-)-ENTEROLACTONES




  (+)-(2S,3S)-Enterolactone   (-)-(2R,3R)-Enterolactone




                       L                R
ENANTIO SELECTIVE DEHYDROXYLATION



 R




 L




ENANTIO SELECTIVE OXIDATION OF DIOLS




 R




 L
DEMETHYLATION PROCEEDS IN EITHER
ENANTIOMER




        ORAL ADMINISTRATION OF A. LAPPA
         DECOCTION TO HUMAN SUBJECTS
Subject:                                         (BMI,        18.6 ± 2.1 kg/m2      22.6 ±
0.4 kg/m2).

Drug:                  (14.5 mM arctiin and 7.5 mM arctigenin)


Dose:    1.0 ml/kg        (= 0.5 g of           /kg       )


                             1              

              -2 day             0 day                                           4 day




Collection of samples:
                                        
             

Sample pretreatment:                    C18-Sep Pak            

Analysis:      LC/MS/MS
URINARY METABOLITES OF HUMAN SUBJECTS
                              AFTER ORAL ADMINISTRATION OF A. LAPPA
                                           DECOCTION

% of dosed arctiin and ARG




                                                                                                                    e
                                                                                                                  lit
                                                                                                                bo
                                                                                                               ta
                                                                                                             Me
                               A   B       C   D   E    F   G   H   I    J    K     L   M Mean
                                               Female                        Male
                                                            Individual                           Dose, 0.5 ml/kg weight




                         Structural Similarity between Tracheloside from
                               Safflower and Arctiin from Burdock




                                       




                                   Tracheloside                                             Arctiin
Time Course of Metabolite Formation after Anaerobic
Incubation of Trachelogenin with Human Intestinal Bacteria

                                   Trachelogenin                     0hr



                                                                     72hr
                                       1

                                                                     96hr



                                                                     120hr
                    4
    332
      2                        5           6
                                                                     168hr

                                                      7




Estimation of Trachelogenin Metabolite on the Basis
               of Mass Spectral Data




                        m/z
           Difference
    Elimination
   Trachelogenin
       388
          M1            374
                   -14
   -Me x1
          M2
           360
                   -28
   -Me x2
          M3
           360
                   -28
   -Me x2
          M4
           346
                   -42
   -Me x3
          M5
           330
                   -58
   -Me x3 -OH x1
          M6
           314
                   -74
   -Me x3 -OH x2
          M7
           298
                   -90
   -Me x3 -OH x3
Metabolic Process of Trachelogenin


                          - Me                    - Me



                                       1                  2
     Trachelogenin                          ‐Me               - Me


                                                  - Me


                                       3                  4
                                                              - OH


                         - OH                     - OH




(-)-Enterolactone, (7)                 6                  5




         Expression of Estrogenic Action
                                                         Physiological Action
                 Co-activator Complex



  Estrogen
                     CBP/p300

                     SRC-1        TF
                                        RNA pol
                 ER ER                               mRNA       Gene Products
                                 TBP
                  ERE            TATA               Target Gene

• Through a complex formation of estrogen receptors, estrogen, co-
activators such as SCR-1, transcription of target genes is
accelerated to induce physiological actions.
• Two types of estrogen receptors ERα and ERβ are reported and
phytoestrogens are more strongly bound to ERβ than ERα in
general.
B/Bmax




                                                                       0
                                                                           10
                                                                                 20
                                                                                      30
                                                                                           40
                                                                                                50
                                                                                                     60




                                                                 -10
                                                            Arctiin
                                                       Arctigenin

                                                    Tracheloside
                                                  Tracherogenin

                                                                 1




                                                                                                                                                                                                             TMB
                                                                 2
                                                                 3
                                                                 4
                                                                 5




                                                                                                          ERα agonist
                                       (-)-Dihydroxyenterolactone
                                                                 6




    B/Bmax % of control (estradiol)
                                                                                      *
                                       (-)-Enterolactone(        7)
                                                (+)-Enterolactone

                                                    (-)-Enterodiol
                                                   (+)-Enterodiol




                                                                                                                                                                            peroxidase 
                                                                                B/Bmax




                                                                       0
                                                                           10
                                                                                 20
                                                                                      30
                                                                                           40
                                                                                                50
                                                                                                     60




                                                                 -10
                                                            Arctiin
                                                                                                                                                                                                                   SRC-1




                                                       Arctigenin




                                                                                                                         Ligand Activity against Erα
                                                    Tracheloside
                                                                                                                                                                                                                   ER




                                                  Tracherogenin

                                                                 1
                                                                                                                                                                                                                           Principle of Assay




                                                                 2
                                                                                                                                                                            Detection antibody horseradish



                                                                 3
                                                                 4




                                                                                                                         Erβ
                                                                 5
                                                                                                                                                                                                                   




                                                                                                          ER β agonist
                                       (-)-Dihydroxyenterolactone
                                                                 6
                                                                                                                                                                            TMB




                                       (-)-Enterolactone(        7)




                                                                                                      *
                                                                                                     *
                                                (+)-Enterolactone

                                                    (-)-Enterodiol



                                                                                                                         ± SE
                                                                                                                                                                                                                   
 TMB




                                                   (+)-Enterodiol
                                                                                                                                                       Oxidation product
STEPWISE DEGRADATION OF PINORESINOL




          Enterococcus faecalis strain PDG-1




MOST OF LIGNANS ARE PRECURSORS OF ENTERODIOL
             AND ENTEROLACTONE
CONVERSION OF PUERARIN
TO EQUOL



                                                            Equol

                Strain PUE
               Strain DZE




                              Daidzein




Jin et al.: Biol.Pharm. Bull., 31, 1621-1625                    Estradiol
(2008)




Characterization of a Human Intestinal Bacterium
     that Transforms Puerarin to Daidzein


                               Strain PUE
                                                        




                                                            Daidzein
       Puerarin




  Dendrograms of phylogenic affiliation of strain PUE based on 16S rRNA gene
DETECTION OF DUTERIUM-LABELED GLUCOSE
              DERIVATIVE BY LC/MS




                        Conclusions

1.  Trachelogenin was demonstrated to convert estrogenic
    enterolactone as well as secoisolarisiresinol diglucoside
    (SDG), arctiin and pinoresinol by human intestinal bacteria
    (HIB). 
                                                   trachelogenin
    and arctiin to (-)-enterolactone by HIB.
                                                ERα       ERβ.
4.  Dehydroxylation and oxidation of lignans by HIB were
    enantioselective as substrates.
5.  Puerarin (C-glucosyl) was converted to estrogenic equol
    through daidzein by HIB.
Coworkers


Contenu connexe

Tendances

BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioMAP® Systems
 
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13Juan Barrera
 
IJERD (www.ijerd.com) International Journal of Engineering Research and Devel...
IJERD (www.ijerd.com) International Journal of Engineering Research and Devel...IJERD (www.ijerd.com) International Journal of Engineering Research and Devel...
IJERD (www.ijerd.com) International Journal of Engineering Research and Devel...IJERD Editor
 
Extraction and determination of fructans (oligofructoses and
Extraction and determination of fructans (oligofructoses andExtraction and determination of fructans (oligofructoses and
Extraction and determination of fructans (oligofructoses andNadejda Petkova
 
DETERMINATION OF MIANSERIN USING TROPAEOLIN-OOO BY ION PAIR FORMATION
DETERMINATION OF MIANSERIN USING TROPAEOLIN-OOO BY ION PAIR FORMATIONDETERMINATION OF MIANSERIN USING TROPAEOLIN-OOO BY ION PAIR FORMATION
DETERMINATION OF MIANSERIN USING TROPAEOLIN-OOO BY ION PAIR FORMATIONRatnakaram Venkata Nadh
 
Metabolomics: data acquisition, pre-processing and quality control
Metabolomics: data acquisition, pre-processing and quality controlMetabolomics: data acquisition, pre-processing and quality control
Metabolomics: data acquisition, pre-processing and quality controlCOST action BM1006
 
Perspectives of identifying Korean genetic variations
Perspectives of identifying Korean genetic variationsPerspectives of identifying Korean genetic variations
Perspectives of identifying Korean genetic variationsHong ChangBum
 

Tendances (15)

BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
 
C K M[1]
C K M[1]C K M[1]
C K M[1]
 
Opioides en la comida
Opioides en la comidaOpioides en la comida
Opioides en la comida
 
Setting Biological Process Specifications
Setting Biological Process SpecificationsSetting Biological Process Specifications
Setting Biological Process Specifications
 
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
 
IJERD (www.ijerd.com) International Journal of Engineering Research and Devel...
IJERD (www.ijerd.com) International Journal of Engineering Research and Devel...IJERD (www.ijerd.com) International Journal of Engineering Research and Devel...
IJERD (www.ijerd.com) International Journal of Engineering Research and Devel...
 
G0342034037
G0342034037G0342034037
G0342034037
 
Koti
KotiKoti
Koti
 
Extraction and determination of fructans (oligofructoses and
Extraction and determination of fructans (oligofructoses andExtraction and determination of fructans (oligofructoses and
Extraction and determination of fructans (oligofructoses and
 
Comparison
ComparisonComparison
Comparison
 
Paper 3_4
Paper 3_4Paper 3_4
Paper 3_4
 
DETERMINATION OF MIANSERIN USING TROPAEOLIN-OOO BY ION PAIR FORMATION
DETERMINATION OF MIANSERIN USING TROPAEOLIN-OOO BY ION PAIR FORMATIONDETERMINATION OF MIANSERIN USING TROPAEOLIN-OOO BY ION PAIR FORMATION
DETERMINATION OF MIANSERIN USING TROPAEOLIN-OOO BY ION PAIR FORMATION
 
Isotopic labeling
Isotopic labelingIsotopic labeling
Isotopic labeling
 
Metabolomics: data acquisition, pre-processing and quality control
Metabolomics: data acquisition, pre-processing and quality controlMetabolomics: data acquisition, pre-processing and quality control
Metabolomics: data acquisition, pre-processing and quality control
 
Perspectives of identifying Korean genetic variations
Perspectives of identifying Korean genetic variationsPerspectives of identifying Korean genetic variations
Perspectives of identifying Korean genetic variations
 

Plus de drugmetabol

김치가 싫다고
김치가 싫다고김치가 싫다고
김치가 싫다고drugmetabol
 
1 김은정과장님
1 김은정과장님1 김은정과장님
1 김은정과장님drugmetabol
 
Presentation (saiki) (5)
Presentation (saiki) (5)Presentation (saiki) (5)
Presentation (saiki) (5)drugmetabol
 
2009 korea slikker_korea_발표용(1)
2009 korea slikker_korea_발표용(1)2009 korea slikker_korea_발표용(1)
2009 korea slikker_korea_발표용(1)drugmetabol
 
2009 hattori metagenomics
2009 hattori metagenomics2009 hattori metagenomics
2009 hattori metagenomicsdrugmetabol
 
2009 약물대사기반 심포지엄-정호상(3)
2009 약물대사기반 심포지엄-정호상(3)2009 약물대사기반 심포지엄-정호상(3)
2009 약물대사기반 심포지엄-정호상(3)drugmetabol
 
6.남영도110923
6.남영도1109236.남영도110923
6.남영도110923drugmetabol
 
2.ginsenoside metabolite 경희대(손동환)
2.ginsenoside metabolite 경희대(손동환)2.ginsenoside metabolite 경희대(손동환)
2.ginsenoside metabolite 경희대(손동환)drugmetabol
 
5.약물대사 발표자료 정혜광-110914
5.약물대사 발표자료 정혜광-1109145.약물대사 발표자료 정혜광-110914
5.약물대사 발표자료 정혜광-110914drugmetabol
 
3. 정병화식약청 사업단_심포지움_2011
3. 정병화식약청 사업단_심포지움_20113. 정병화식약청 사업단_심포지움_2011
3. 정병화식약청 사업단_심포지움_2011drugmetabol
 
1.2011 사업단 심포지움_김은정
1.2011 사업단 심포지움_김은정1.2011 사업단 심포지움_김은정
1.2011 사업단 심포지움_김은정drugmetabol
 

Plus de drugmetabol (13)

김치가 싫다고
김치가 싫다고김치가 싫다고
김치가 싫다고
 
1 김은정과장님
1 김은정과장님1 김은정과장님
1 김은정과장님
 
Presentation (saiki) (5)
Presentation (saiki) (5)Presentation (saiki) (5)
Presentation (saiki) (5)
 
2009 korea slikker_korea_발표용(1)
2009 korea slikker_korea_발표용(1)2009 korea slikker_korea_발표용(1)
2009 korea slikker_korea_발표용(1)
 
2009 hattori metagenomics
2009 hattori metagenomics2009 hattori metagenomics
2009 hattori metagenomics
 
2009 약물대사기반 심포지엄-정호상(3)
2009 약물대사기반 심포지엄-정호상(3)2009 약물대사기반 심포지엄-정호상(3)
2009 약물대사기반 심포지엄-정호상(3)
 
7. 정해영
7. 정해영7. 정해영
7. 정해영
 
6.남영도110923
6.남영도1109236.남영도110923
6.남영도110923
 
2.ginsenoside metabolite 경희대(손동환)
2.ginsenoside metabolite 경희대(손동환)2.ginsenoside metabolite 경희대(손동환)
2.ginsenoside metabolite 경희대(손동환)
 
5.약물대사 발표자료 정혜광-110914
5.약물대사 발표자료 정혜광-1109145.약물대사 발표자료 정혜광-110914
5.약물대사 발표자료 정혜광-110914
 
4.ly korea
4.ly korea4.ly korea
4.ly korea
 
3. 정병화식약청 사업단_심포지움_2011
3. 정병화식약청 사업단_심포지움_20113. 정병화식약청 사업단_심포지움_2011
3. 정병화식약청 사업단_심포지움_2011
 
1.2011 사업단 심포지움_김은정
1.2011 사업단 심포지움_김은정1.2011 사업단 심포지움_김은정
1.2011 사업단 심포지움_김은정
 

Dernier

Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 

Dernier (20)

Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 

2 하토리교수

  • 1. Naturally-occurring Phytoestrogen Precursors Are Converted to Estrogenic Compounds by Human Intestinal Bacteria Masao Hattori Emeritus Professor, University of Toyama On Plant Isoflavones and Lignans In an epidemiologic study, the prevalence of breast cancer and prostate cancer was lower in Japan and Finland compared it with U.S.A As a low factor of the prevalence, a Japanese soy bean and Finnish rye bread were considered as the candidates, which contain so called phytoestrogens, isoflavonoids and lignans. Since phytoestrogens structurally resemble estradiol, they have estrogenic and anti-estrogenic activities and an incidence of prostate cancer or breast cancer may decrease depending on the blood concentrations of phytoestrogens (reverse correlation).
  • 2. METABOLISM OF SDG BY HUMAN INTESTINAL FLORA METABOLISM OF ARCTIIN BY HUMAN INTESTINAL FLORA
  • 3. CIRCULAR DICHROISM OF (+)- AND (-)-ENTEROLACTONES MIRROR IMAGES OF (+)- AND (-)-ENTEROLACTONES (+)-(2S,3S)-Enterolactone (-)-(2R,3R)-Enterolactone L R
  • 4. ENANTIO SELECTIVE DEHYDROXYLATION R L ENANTIO SELECTIVE OXIDATION OF DIOLS R L
  • 5. DEMETHYLATION PROCEEDS IN EITHER ENANTIOMER ORAL ADMINISTRATION OF A. LAPPA DECOCTION TO HUMAN SUBJECTS Subject: (BMI, 18.6 ± 2.1 kg/m2 22.6 ± 0.4 kg/m2). Drug: (14.5 mM arctiin and 7.5 mM arctigenin) Dose: 1.0 ml/kg (= 0.5 g of /kg ) 1 -2 day 0 day 4 day Collection of samples: Sample pretreatment: C18-Sep Pak Analysis: LC/MS/MS
  • 6. URINARY METABOLITES OF HUMAN SUBJECTS AFTER ORAL ADMINISTRATION OF A. LAPPA DECOCTION
 % of dosed arctiin and ARG e lit bo ta Me A B C D E F G H I J K L M Mean Female Male Individual Dose, 0.5 ml/kg weight Structural Similarity between Tracheloside from Safflower and Arctiin from Burdock Tracheloside Arctiin
  • 7. Time Course of Metabolite Formation after Anaerobic Incubation of Trachelogenin with Human Intestinal Bacteria Trachelogenin 0hr 72hr 1 96hr 120hr 4 332 2 5 6 168hr 7 Estimation of Trachelogenin Metabolite on the Basis of Mass Spectral Data m/z Difference Elimination Trachelogenin 388 M1 374 -14 -Me x1 M2 360 -28 -Me x2 M3 360 -28 -Me x2 M4 346 -42 -Me x3 M5 330 -58 -Me x3 -OH x1 M6 314 -74 -Me x3 -OH x2 M7 298 -90 -Me x3 -OH x3
  • 8. Metabolic Process of Trachelogenin - Me - Me 1 2 Trachelogenin ‐Me - Me - Me 3 4 - OH - OH - OH (-)-Enterolactone, (7) 6 5 Expression of Estrogenic Action Physiological Action Co-activator Complex Estrogen CBP/p300 SRC-1 TF RNA pol ER ER mRNA Gene Products TBP ERE TATA Target Gene • Through a complex formation of estrogen receptors, estrogen, co- activators such as SCR-1, transcription of target genes is accelerated to induce physiological actions. • Two types of estrogen receptors ERα and ERβ are reported and phytoestrogens are more strongly bound to ERβ than ERα in general.
  • 9. B/Bmax 0 10 20 30 40 50 60 -10 Arctiin Arctigenin Tracheloside Tracherogenin 1 TMB 2 3 4 5 ERα agonist (-)-Dihydroxyenterolactone 6 B/Bmax % of control (estradiol) * (-)-Enterolactone( 7) (+)-Enterolactone (-)-Enterodiol (+)-Enterodiol peroxidase B/Bmax 0 10 20 30 40 50 60 -10 Arctiin SRC-1 Arctigenin Ligand Activity against Erα Tracheloside ER Tracherogenin 1 Principle of Assay 2 Detection antibody horseradish 3 4 Erβ 5 ER β agonist (-)-Dihydroxyenterolactone 6 TMB (-)-Enterolactone( 7) * * (+)-Enterolactone (-)-Enterodiol ± SE TMB (+)-Enterodiol Oxidation product
  • 10. STEPWISE DEGRADATION OF PINORESINOL Enterococcus faecalis strain PDG-1 MOST OF LIGNANS ARE PRECURSORS OF ENTERODIOL AND ENTEROLACTONE
  • 11. CONVERSION OF PUERARIN TO EQUOL
 Equol Strain PUE Strain DZE Daidzein Jin et al.: Biol.Pharm. Bull., 31, 1621-1625 Estradiol (2008) Characterization of a Human Intestinal Bacterium that Transforms Puerarin to Daidzein Strain PUE Daidzein Puerarin Dendrograms of phylogenic affiliation of strain PUE based on 16S rRNA gene
  • 12. DETECTION OF DUTERIUM-LABELED GLUCOSE DERIVATIVE BY LC/MS Conclusions 1.  Trachelogenin was demonstrated to convert estrogenic enterolactone as well as secoisolarisiresinol diglucoside (SDG), arctiin and pinoresinol by human intestinal bacteria (HIB).   trachelogenin and arctiin to (-)-enterolactone by HIB.   ERα ERβ. 4.  Dehydroxylation and oxidation of lignans by HIB were enantioselective as substrates. 5.  Puerarin (C-glucosyl) was converted to estrogenic equol through daidzein by HIB.